Cesar de la Fuente

Cesar de la Fuente uses machine learning to mine phage genomes for novel anti-cancer peptides and to design engineered phage-derived therapeutics with enhanced tumor-targeting properties. His computational approaches have discovered previously unknown antimicrobial and anti-cancer molecules encoded in phage genomes. He has advanced AI-driven approaches to engineering phage components for cancer therapeutic applications.